<code id='E4D7B173CF'></code><style id='E4D7B173CF'></style>
    • <acronym id='E4D7B173CF'></acronym>
      <center id='E4D7B173CF'><center id='E4D7B173CF'><tfoot id='E4D7B173CF'></tfoot></center><abbr id='E4D7B173CF'><dir id='E4D7B173CF'><tfoot id='E4D7B173CF'></tfoot><noframes id='E4D7B173CF'>

    • <optgroup id='E4D7B173CF'><strike id='E4D7B173CF'><sup id='E4D7B173CF'></sup></strike><code id='E4D7B173CF'></code></optgroup>
        1. <b id='E4D7B173CF'><label id='E4D7B173CF'><select id='E4D7B173CF'><dt id='E4D7B173CF'><span id='E4D7B173CF'></span></dt></select></label></b><u id='E4D7B173CF'></u>
          <i id='E4D7B173CF'><strike id='E4D7B173CF'><tt id='E4D7B173CF'><pre id='E4D7B173CF'></pre></tt></strike></i>

          comprehensive

          comprehensive

          author:comprehensive    Page View:4828
          Calling Bullshit course University of Washington
          Screenshot via callingbullshit.org

          Tired of alternative facts, fake news, and breathless hyperbole, two professors at the University of Washington are trying to strike a blow for science.

          Their weapon? A new course: “Calling Bullshit In the Age of Big Data.”

          advertisement

          The class website and colorful syllabus went online last month and almost instantly went viral.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          leisure time

          Hollywood unions extend contract negotiations for actors
          Hollywood unions extend contract negotiations for actors

          1:36HollywoodwritersandtheirsupportersfromtheSAGAFTRAactors'unionwalkthepicketlineoutsideWarnerBrosS

          read more
          FogPharma raises $145 million in rare Series E round
          FogPharma raises $145 million in rare Series E round

          FogPharmaCEOMathaiMammenBostonGlobePhotoImportOncologystartupFogPharmajustcloseda$145millionSeriesEr

          read more
          Drug repurposing or repositioning? The language matters
          Drug repurposing or repositioning? The language matters

          AdobeFindinganewmedicineisnevereasy.Butdevelopingtreatmentsforpatientswithrarediseases—conditionstha

          read more

          Readout Newsletter: Novo Nordisk trial, Verve base editing, etc

          LISELOTTESABROE/AFP/GettyImagesWanttostayontopofthescienceandpoliticsdrivingbiotechtoday? Signup tog